Delivery Order SPE2DB20D1004-SPE2DB25FNFBB
Award Date
2/20/25
Potential Completion Date
2/21/25
Potential Value
$1.6K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,544.06, is for the supply of OTREXUP 12.5 MG/0.4 ML AUTOINJ 0.4ML, a medical product. It is a firm fixed-price delivery order contract with a period of performance through January 22, 2024. The contract is not associated with any set-aside designation. AmerisourceBergen Drug Corp holds a...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of OTREXUP 25 MG/0.4 ML AUTO-INJ 0.4ML medical products. The firm-fixed-price contract has a ceiling value of $11,517.13 and a completion date of November 29, 2024. The contract is not designated as a set-aside. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at...
This is a firm fixed price delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation. The contract is for the delivery of OTREXUP 25 MG/0.4 ML AUTO-INJ 0.4ML, a specialty pharmaceutical product, to support military treatment programs and facilities. The delivery order has a ceiling value of $2,473.13 and a period of performance through March 18, 2024. AmerisourceBergen Drug Corp...
This firm fixed price delivery order was awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, a leading global pharmaceutical sourcing and distribution services company. The order is for OTREXUP 15 MG/0.4 ML AUTO-INJ 0.4ML, a specialty pharmaceutical product, with a ceiling value of $2,599.92 and a period of performance through March 25, 2024. The contract does not have a set-aside designation. AmerisourceBergen Drug Corp...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp for the supply of OTREXUP 20 MG/0.4 ML AUTO-INJ 0.4ML, a pharmaceutical product. The contract has a ceiling value of $1,382.31 and runs through September 9, 2024. It is a firm fixed-price contract with no set-aside designation. AmerisourceBergen Drug Corp is a major pharmaceutical distributor that holds several Indefinite Delivery Contracts (IDCs) with federal agencies,...
This federal contract award, with ID SPE2DB22D6029|SPE2DB24FU1WT, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office Division. The $1,603.31 firm-fixed-price delivery order is for the supply of OTREXUP 20 MG/0.4 ML AUTO-INJ 0.4ML, a pharmaceutical product. The contract has an ultimate completion date of August 5, 2024. Amerisourcebergen is a major supplier of pharmaceutical products and medical supplies to the U.S. federal government, with numerous...
The Defense Logistics Agency awarded a $881.77 firm fixed price delivery order to Amerisourcebergen Drug Corporation for 4562125900 OTREXUP 25 MG/0.4 ML auto-injectors. The delivery order was issued under an indefinite-delivery/indefinite-quantity contract vehicle to supply pharmaceutical products and services in support of DLA and Department of Defense requirements. Performance will occur at Amerisourcebergen's facility in Conshohocken, Pennsylvania over a period of one day, from September 11...
This is a federal delivery order award made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corporation, a major pharmaceutical distributor. The $11,578.02 firm-fixed-price contract is for the supply of OTEZLA 30 MG TABLET 60S medication. The contract has an ultimate completion date of August 15, 2024. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued up to $999,999,999 through December 2025, for delivering a...
This is a delivery order award under an existing Indefinite Delivery Contract (IDC) held by AmerisourceBergen Drug Corp, a major pharmaceutical distributor, with the Defense Logistics Agency (DLA) Troop Support Medical. The contract, valued at $4,268.27, is for the delivery of OTEZLA 30 MG TABLET 60S, a pharmaceutical product. The contract is a Firm Fixed Price arrangement without any set-aside designation, indicating open competition. AmerisourceBergen, the prime contractor, is responsible...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor in the United States. The $24,044.52 firm-fixed-price contract is for the supply of ORENCIA CLICKJECT 125 MG/MLML, a prescription medication. The contract has an ultimate completion date of October 16, 2024 and is not designated as a set-aside award. Amerisourcebergen holds a large Indefinite Delivery Contract (IDC) with the DLA Troop Support...